Analysis of m7G-related signatures in the tumor immune microenvironment and identification of clinical prognostic regulators in ovarian cancer.

Ovarian cancer (OV) is the most lethal gynecological malignancy in the world. At present, the effect of m7G modification-related genes on the development of ovarian cancer remains unclear. We performed consensus clustering of ovarian cancer samples based on the expression of 24 m7G modification-related genes, and obtained 2 subtypes. There were some differences in immune cell infiltration between the two subtypes. Furthermore, enrichment analysis showed that differential genes were mainly enriched in several pathways and biological processes, including positive translation regulation and TRAPP complex. Multivariate cox regression analysis confirmed two genes (DCP2 and NUDT16) related to prognosis for the construction of risk score prediction models. The risk map of survival status showed that the high-risk samples had a shorter survival time (p<0.05). Risk score was an independent prognostic factor for OV and correlated with immunotherapy response. We also performed network analysis for DCP2 and NUDT16. We further explored the effects of the genes on cellular function and prognosis. In conclusion, this study provided a new perspective for the development mechanism of ovarian cancer.